<DOC>
	<DOCNO>NCT00560209</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ONO-1101 patient schedule coronary angiography , double-blind , randomize , placebo-controlled , parallel group , multi-center study .</brief_summary>
	<brief_title>Study ONO-1101 Patients Scheduled Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Landiolol</mesh_term>
	<criteria>20 year age old Heart rate le 90 beats/min 70 beats/min enter CT room Previous allergic reaction contrast agent Renal failure Asthma Concomitant betareceptor block agent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-1101</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Multi-slice CT</keyword>
</DOC>